durvalumab,rovalpituzumab tesirine
astrazeneca,abbvie
['drup', 'rova,(-approval)']
very interesting talk by #saharvanwalwiikvabdornkoshrovani on the dutch on collecting data from early access programmet in the #dap protocol to build evidence. and on the potential for data aggregation with the drup-like trials. #esmo2022 
Director, Institute for Cancer Research, Oslo University Hospital; Group Leader, Dept. of  Cancer Immunology, Professor Inst. Clin. Medicine, University of Oslo